Primary Record
GSK-3 Inhibitor IX
- In stock
- 8,122 g
- Purity
- 98.4 %
- CAS
- 667463-62-9
Compound Identifiers & Properties
- CAS
- 667463-62-9
- PubChem CID
- 448949
- SMILES
- C1=CC=C2C(=C1)C(=C(N2)C3=C(NC4=C3C=CC(=C4)Br)O)N=O
- Canonical SMILES
- O=Nc1c(-c2c(O)[nH]c3cc(Br)ccc23)[nH]c2ccccc12
Names & Synonyms
- GSK-3 Inhibitor IX
- 6-BROMOINDIRUBIN-3'-OXIME
- 667463-62-9
- GSK 3 Inhibitor IX
- 6BIO
- 6-bromoindirubin-3-oxime
- 6-BIO
- BIO
- 6BIO cpd
- indirubin deriv. 7a
- GSK 3B Inhibitor IX
- 6-BIO (racemic)
- GSK-3-inhibitor-IX
- AC1NRAET
- 1uv5
- BIO?
- GSK 3 IX
- GSK-3 Inhibitor IX (BIO)
- (2'Z,3'E)-6-Bromoindirubin-3'-oxime
- C16H10BrN3O2
- D06OAH
- D0P3XL
- 6-bromo-indirubin-3'oxime
- CHEMBL243555
- BIO; 6-BIO
- 6-bromoindirubin-3''-oxime
- 6-Bromo-indirubin-3/'oxime
- CHEMBL5410800
- MLS001074886
- (2Z,3E)-6-Bromoindirubin-3'-oxime
- SCHEMBL470802
- 6-Bromoindirubin-3 -oxime
- CHEMBL355496
- CHEMBL409450
- CMNPD13753
- GTPL5974
- orb1307114
- SCHEMBL4997980
- SCHEMBL8246737
- CHEMBL2178734
- MLS 2052
- MLS-2052
- SCHEMBL14088703
- SCHEMBL15565919
- SCHEMBL21067440
- SCHEMBL23042946
- SCHEMBL29361130
- SCHEMBL29715875
- SCHEMBL30249771
- CHEBI:86290
- CHEBI:91343
- CTK8E9656
- AOB4191
- DTXSID60648023
- EX-A689
- MFCD08705318
- SAQUSDSPQYQNBG-UHFFFAOYSA-N
- GLXC-03282
- HMS2230G20
- HMS3229G18
- HMS3262K08
- HMS3265E19
- HMS3265E20
- HMS3265F19
- HMS3265F20
- HMS3374K01
- HMS3413H16
- HMS3648C22
- HMS3653G17
- HMS3677H16
- 6-bromoindirubin-3'-oxime (BIO)
- BCP07234
- InSolution™ GSK-3 Inhibitor IX
- BIO, >=98% (HPLC)
- Tox21_500773
- 2268AH
- BDBM50012188
- BDBM50191406
- BDBM50526697
- BDBM50619014
- EBC-13151
- EBC-84022
- HB1259
- HSCI1_000232
- IN1314
- MFCD28142829
- NSC737347
- NSC745931
- s7198
- ZINC18128386
- ZINC18128389
- AKOS024457468
- AKOS026750263
- AKOS030238964
- AKOS032947350
- ZINC100469404
- ZINC100493712
- CCG-101292
- CCG-208082
- CID5287844
- CS-3360
- DB03444
- EBC-656115
- KIN001-043
- LP00773
- NSC-737347
- NSC-745931
- SDCCGSBI-0086755.P007
- SDCCGSBI-0633754.P001
- CID11405589
- BIO (6-Bromoindirubin-3_acute_-oxime)
- NCGC00094112-01
- NCGC00094112-02
- NCGC00094112-03
- NCGC00094112-04
- NCGC00094112-06
- NCGC00094112-15
- NCGC00261458-01
- 4CA-0280
- AC-32731
- AK176375
- AN-27620
- AS-55790
- BB162775
- BC600306
- DA-33591
- HY-10580
- PD182864
- SMR000568408
- 6-bromo-3-(3-nitroso-1H-indol-2-yl)-1H-indol-2-ol
- B1538
- B4006
- NS00071565
- SW219792-1
- J1.982.273G
- J3.111.562K
- KS-00001549
- K00001
- MLS-0388607.0001
- W13430
- (2Z,3E)-6'-Bromo-3-(hydroxyimino)-[2,3'-biindolinylidene]-2'-one
- EN300-1692898
- GSK-3 Inhibitor IX - CAS 667463-62-9
- (2′Z,3′E)-6-Bromoindirubin-3′-oxime
- A867399
- SR-01000838093
- (2Z,3E)-6'-bromo-2,3'-biindole-2',3(1H,1'H)-dione 3-oxime
- 6BIO;GSK 3 IX;GSK 3 Inhibitor IX;MLS 2052
- SR-01000838093-3
- (3E)-6'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-OXIME
- BRD-K04923131-001-14-7
- BRD-K04923131-001-15-4
- Q27077902
- Q27094369
- Q27163220
- InSolution GSK-3 Inhibitor IX - CAS 667463-62-9
- Z199053426
- (2E,3E)-6'-bromo-3-(hydroxyimino)-[2,3'-biindolinylidene]-2'-one
- 6-bromo-3-[3-(hydroxyamino)indol-2-ylidene]indolin-2-one
- 6 -Bromo-delta2,3 -biindoline-3,2 -dione 3-oxime
- 6-bromo-3-[3-(hydroxyamino) indol-2-ylidene]-1h-indol-2-one
- 6-bromo-3-[3-(hydroxyamino)-2-indolylidene]-1H-indol-2-one
- 710323-58-3
- BRW
- (3Z)-6-bromo-3-[3-(hydroxyamino)indol-2-ylidene]-1H-indol-2-one
- (Z)-6'-Bromo-1H,1'H-[2,3']biindolylidene-3,2'-dione 3-oxime
- (Z,3E)-6'-bromo-3-(hydroxyimino)-1',2'-dihydro-1H,3H-[2,3'-biindolyliden]-2'-one
- 6 -Bromo-3-(hydroxyimino)-delta2,3 -bi[indoline]-2 -one
- (3Z)-6-Bromo-3-[(3E)-3-hydroxyimino-1H-indol-2-ylidene]-1H-indol-2-one
- (3Z)-6-bromo-3-[(3E)-3-hydroxyiminoindolin-2-ylidene]indolin-2-one
- (Z)-6''-Bromo-1H,1''H-[2,3'']biindolylidene-3,2''-dione 3-oxime
- 6-bromo-3-[(3E)-3-(hydroxyimino)-1H-indol-2-ylidene]-1H-indol-2-one
- (Z)-6'-bromo-3-(hydroxyamino)-1',2'-dihydro-[2,3'-biindolyliden]-2'-one
- (Z,3E)-6'-BROMO-3-(HYDROXYIMINO)-1H,1'H-[2,3'-BIINDOLYLIDEN]-2'-ONE
- 1,3-Dihydro-6 -bromo-3-(hydroxyimino)-delta2,3 -bi[2H-indole]-2 (1 H)-one
- 3-[3-(Hydroxyimino)-1H-indole-2(3H)-ylidene]-6-bromo-1H-indole-2(3H)-one
- 6'-bromo-3-(hydroxyimino)-1',2'-dihydro-1H,3H-[2,3'-biindolyliden]-2'-one
- 6-Bromo-3-[3-(hydroxyamino)-2H-indol-2-ylidene]-1,3-dihydro-2H-indol-2-one
- 6-bromo-3-[3-(hydroxyamino)-2H-indol-2-ylidene]-2,3-dihydro-1H-indol-2-one
- 6-Bromo-3-[3-(hydroxyimino)-1,3-dihydro-2H-indol-2-ylidene]-1,3-dihydro-2H-indol-2-one
- 6-Bromo-3-[3-(hydroxyimino)-1H-indole-2(3H)-ylidene]-1H-indole-2(3H)-one
- (2 inverted exclamation mark Z,3 inverted exclamation mark E)-6-Bromoindirubin-3 inverted exclamation marka-oxime
- (2Z)-1,3-Dihydro-6 -bromo-3-[(E)-hydroxyimino]-delta2,3 -bi[2H-indole]-2 (1 H)-one
- (3Z)-6-bromo-3-[(3E)-3-(hydroxyimino)-1,3-dihydro-2H-indol-2-ylidene]-1,3-dihydro-2H-indol-2-one
- 2H-Indol-2-one, 6-bromo-3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-, (3Z)-
- 2H-Indol-2-one,6-bromo-3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-,(3Z)-
- 6-bromo-3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-(3Z)-2H-indol-2-one